Author
University Hospital MünsterORCID 0000-0002-7609-5021Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
6 papers
Recent·Most cited
Veronika Buršić, Heng Luo, Clémence Henon…·Florencia Cidre‐Aranaz
The paper identifies LMO7 as a fusion-regulated driver of metastasis in Ewing sarcoma using spatial transcriptomics and integrates clinical data to show its association with poor outcomes.
Aubrey K. Hubbard, Hélène Neyret‐Kahn, Martina Müller‐Nurasyid…·Mitchell J. Machiela
This study identifies 14 susceptibility loci for Ewing sarcoma through a genome-wide association meta-analysis, revealing genetic interactions with somatic EWSR1::FLI1 fusions.
Alina Ritter, Malenka Zimmermann, Florian H. Geyer…·Florencia Cidre‐Aranaz
This study identifies CXADR as a driver of Ewing sarcoma metastasis and shows that targeting AKT signaling with Capivasertib enhances chemotherapy efficacy in CXADR-high tumors.
Florencia Cidre‐Aranaz, Claudia Magrin, Malenka Zimmermann…·Stéphanie Papin
This study finds that high Tau expression in Ewing sarcoma cells reduces invasion and improves patient survival.
Florian H. Geyer, Alina Ritter, Seneca S. Kinn-Gurzo…·Florencia Cidre‐Aranaz
The paper identifies CACNA2D2 as a super-enhancer-driven target of EWSR1::WT1 and demonstrates its utility as a diagnostic biomarker for DSRCT.
Lorena Heinst, Kwang-Seok Lee, Ruth Berthold…·Marcel Trautmann
This study identifies WEE1 kinase activity as a therapeutic target in FUS::DDIT3-driven myxoid liposarcoma by showing its role in replication stress tolerance and cell survival.